Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Illumina, Inc. - Common Stock (NQ:ILMN)

273.64 -20.05 (-6.83%)
Delayed Quote Updated: 12:30 PM EDT, Oct 6, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Illumina, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
39 40 Next >
Tuesday's session: gap up and gap down stock in the S&P500 index ↗
Via Chartmill
News headline image
Stocks making big moves yesterday: Harley-Davidson, Illumina, TechnipFMC, Upstart, and DraftKings
Check out the companies making headlines yesterday: Harley-Davidson (NYSE:HOG): American motorcycle manufacturing company Harley-Davidson (NYSE:HOG) rose by ... 
Via StockStory
Topics Artificial Intelligence
News headline image
Why PacBio (PACB) Stock Is Trading Up Today
What Happened? Shares of genomics company Pacific Biosciences of California (NASDAQ:PACB) jumped 9.9% in the afternoon session after EpiSign Inc. and Geneyx ... 
Via StockStory
Topics Artificial Intelligence
News headline image
Illumina (ILMN) Shares Skyrocket, What You Need To Know
What Happened? Shares of genomics company Illumina (NASDAQ:ILMN) jumped 7.7% in the afternoon session after Wall Street analysts lifted their price targets d... 
Via StockStory
Topics Artificial Intelligence
Uncover the latest developments among S&P500 stocks in today's session. ↗
Via Chartmill
Which S&P500 stocks are moving on Monday? ↗
Via Chartmill
News headline image
3 Reasons to Buy Grail (GRAL) Hand Over Fist in October ↗
The cancer blood test maker could have a bright future. 
Via The Motley Fool
News headline image
Why Is PacBio (PACB) Stock Soaring Today
What Happened? Shares of genomics company Pacific Biosciences of California (NASDAQ:PACB) jumped 29.7% in the afternoon session after EpiSign announced the l... 
Via StockStory
Topics Artificial Intelligence
News headline image
Where Will Illumina Stock Be in 5 Years If Its AI Bet Pays Off? ↗
Illumina's AI strategy is reshaping the investment case. See how sequencing, biological data, and drug-discovery partnerships could change what drives the company next. 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
3 Reasons to Sell ILMN and 1 Stock to Buy Instead
What a fantastic six months it’s been for Illumina. Shares of the company have skyrocketed 126%, hitting $273.47. This was partly due to its solid quarterly ... 
Via StockStory
News headline image
Waters Tops Growth Outlook as AI Demand, BD Integration Fuel Momentum ↗
Waters (NYSE:WAT) President and Chief Executive Officer Udit Batra said the company’s second-quarter performance exceeded expectations, supported by broad-based growth in its legacy analytical-science... 
Via MarketBeat
Topics Artificial Intelligence
News headline image
AI-Assisted Clinical Research Could Accelerate Personalized Medicine ↗
The global personalized medicine market was valued at USD 567.1 billion in 2024. It is projected to reach USD 656.5 billion in 2026 and USD 1,196.2 billion 
Via Talk Markets
Topics Artificial Intelligence
News headline image
3 Healthcare Stocks with Warning Signs
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Shareholders who bet on the industry... 
Via StockStory
News headline image
Automated Labeling Tools Are Modernizing the AI Training Dataset Market ↗
The global AI training dataset market was valued at USD 3.2 billion in 2025 and is projected to reach USD 16.3 billion by 2033, expanding from USD 3.9 bill 
Via Talk Markets
Topics Artificial Intelligence
News headline image
1 Surging Stock to Target This Week and 2 We Question
Great things are happening to the stocks in this article. They’re all outperforming the market over the last month because of positive catalysts such as a ne... 
Via StockStory
News headline image
This Copart Analyst Turns Bullish; Here Are Top 2 Upgrades For Friday ↗
Analysts upgraded Copart, Orchestra BioMed, Illumina, Martin Marietta Materials and Waters, raising their price targets. 
Via Benzinga
News headline image
Bloom Energy Is Joining the S&P 500: Is the Stock Still a Buy After Its Massive Run? ↗
Bloom Energy has secured a spot in the S&P 500 as part of its quarterly rebalancing. 
Via The Motley Fool
Topics Artificial Intelligence Energy Stocks
News headline image
Bloom Energy, Illumina, Everpure Rise On S&P 500 Inclusion ↗
The fuel-cell company will join on Sept. 21, along with Illumina and Everpure. 
Via Investor's Business Daily
Topics Stocks
News headline image
Saudi Arabia Internet of Medical Things Market 2031: AI, Wearables & Smart Medical Devices Drive Transformation ↗
Industry Key HighlightsThe Saudi Arabia IoMT Market is expected to increase from USD 289.34 million in 2025 to USD 676.63 million by 2031.The market is pro 
Via Talk Markets
Topics Artificial Intelligence
News headline image
The Market Just Told You Which Layer Of AI Biology It Is Paying For
Issued on behalf of MindWalk Holdings Corp. 
From Market Updates
Via GlobeNewswire
News headline image
3 High-Flying Stocks We Keep Off Our Radar
Expensive stocks often command premium valuations because the market thinks their business models are exceptional. However, the downside is that high expecta... 
Via StockStory
News headline image
$100 Invested In Illumina 20 Years Ago Would Be Worth This Much Today ↗
Illumina (NASDAQ:ILMN) has outperformed the market over the past 20 years by 4.32% on an annualized basis producing an average annual return of 13.55%. Currently, Illumina has a market capitalization... 
Via Benzinga
News headline image
1 Large-Cap Stock with Competitive Advantages and 2 We Find Risky
Large-cap stocks usually command their industries because they have the scale to drive market trends. The flip side though is that their sheer size can limit... 
Via StockStory
News headline image
Winners And Losers Of Q2: Illumina (NASDAQ:ILMN) Vs The Rest Of The Life Sciences Tools & Services Stocks
Looking back on life sciences tools & services stocks’ Q2 earnings, we examine this quarter’s best and worst performers, including Illumina (NASDAQ:ILMN) and... 
Via StockStory
Topics Artificial Intelligence
News headline image
Precision Medicine Software Market: Companion Diagnostics Rise ↗
Precision medicine software has moved from a niche research tool to a core piece of modern healthcare infrastructure. As genomic sequencing gets cheaper an 
Via Talk Markets
Topics Artificial Intelligence
News headline image
1 Unpopular Stock That Deserves Some Love and 2 Facing Headwinds
Wall Street’s bearish price targets for the stocks in this article signal serious concerns. Such forecasts are uncommon in an industry where maintaining cord... 
Via StockStory
News headline image
Waters Q2 Earnings Call Highlights ↗
Waters (NYSE:WAT) reported second-quarter 2026 revenue of $1.645 billion, driven by 9% organic constant-currency growth and a 4% increase in revenue from its acquired Biosciences and Diagnostic... 
Via MarketBeat
Topics Earnings
News headline image
Biotech AI Retail Solutions Market to Reach USD 7.12 Billion by 2034 ↗
According to a new report from Intel Market Research, the global Biotech AI Retail Solutions market was valued at USD 3.45 billion in 2025 and is projected 
Via Talk Markets
Topics Artificial Intelligence
News headline image
5 Must-Read Analyst Questions From Illumina’s Q2 Earnings Call
Illumina’s second quarter results reflected strong execution in its core clinical sequencing business, with management highlighting robust demand from U.S. a... 
Via StockStory
Topics Earnings
News headline image
Here's How Much $1000 Invested In Illumina 20 Years Ago Would Be Worth Today ↗
Illumina (NASDAQ:ILMN) has outperformed the market over the past 20 years by 3.84% on an annualized basis producing an average annual return of 13.26%. Currently, Illumina has a market capitalization... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
39 40 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.